Assyro AI

FDA Orange Book · active-ingredient family

Dextrose; sodium chloride

Dextrose; sodium chloride is approved as 27 brand and 5 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

27

Brand (NDA)

5

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · injectable

ProductApplicantApplicationTEApproved
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERRLDBAXTER HLTHCARENDA 016697APApproved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERRLDOTSUKA ICU MEDCLNDA 017606APApproved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINERRLDOTSUKA ICU MEDCLNDA 017799APApproved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERRLDOTSUKA ICU MEDCLNDA 017607APApproved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERRLDOTSUKA ICU MEDCLNDA 017585APApproved Prior to Jan 1, 1982
DEXTROSE 10% AND SODIUM CHLORIDE 0.11% IN PLASTIC CONTAINER×16B BRAUNNDA 019631Feb 24, 1988
DEXTROSE 5% AND SODIUM CHLORIDE 0.225% IN PLASTIC CONTAINERABBOTTNDA 019482Oct 04, 1985
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINERABBOTTNDA 019486Oct 04, 1985
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERABBOTTNDA 019484Oct 04, 1985
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERABBOTTNDA 019483Oct 04, 1985
DEXTROSE 10% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINERB BRAUNNDA 018386Approved Prior to Jan 1, 1982
DEXTROSE 10% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERB BRAUNNDA 018229Approved Prior to Jan 1, 1982
DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERB BRAUNNDA 018047Approved Prior to Jan 1, 1982
DEXTROSE 10% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERBAXTER HLTHCARENDA 016696Approved Prior to Jan 1, 1982
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINER×5B BRAUNNDA 018030Approved Prior to Jan 1, 1982
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERHOSPIRANDA 018096Approved Prior to Jan 1, 1982
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERB BRAUNNDA 018376Approved Prior to Jan 1, 1982
DEXTROSE 3.3% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINERABBOTTNDA 018055Approved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINERMILESNDA 018399Approved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINERMILESNDA 018501Approved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERMILESNDA 018400Approved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERB BRAUNNDA 018026Approved Prior to Jan 1, 1982
DEXTROSE 5% AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERMILESNDA 018500Approved Prior to Jan 1, 1982
DEXTROSE 5% IN SODIUM CHLORIDE 0.2% IN PLASTIC CONTAINERBAXTER HLTHCARENDA 016689APApproved Prior to Jan 1, 1982
DEXTROSE 5% IN SODIUM CHLORIDE 0.33% IN PLASTIC CONTAINERBAXTER HLTHCARENDA 016687APApproved Prior to Jan 1, 1982
DEXTROSE 5% IN SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERBAXTER HLTHCARENDA 016683APApproved Prior to Jan 1, 1982
DEXTROSE 5% IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINERBAXTER HLTHCARENDA 016678APApproved Prior to Jan 1, 1982

Generic (ANDA) products (5)

ProductApplicantApplicationTEApproved
DEXTROSE 5% AND SODIUM CHLORIDE 0.225%FRESENIUS KABI USAANDA 211221APSep 15, 2020
DEXTROSE 5% AND SODIUM CHLORIDE 0.45%FRESENIUS KABI USAANDA 211276APSep 15, 2020
DEXTROSE 5% AND SODIUM CHLORIDE 0.9%FRESENIUS KABI USAANDA 211211APSep 14, 2020
DEXTROSE 5% AND SODIUM CHLORIDE 0.3% IN PLASTIC CONTAINERFRESENIUS KABI USAANDA 211194APAug 26, 2020
DEXTROSE 2.5% AND SODIUM CHLORIDE 0.45% IN PLASTIC CONTAINERFRESENIUS KABI USAANDA 211190APDec 20, 2019

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Dextrose; sodium chloride — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.